Modern Diagnostic IPO
Market Sentiment
IPO Details
Market Lot Size
IPO Reservation
Financial Analysis
| Metric | 2023 | 2024 | 2025 | June 2025 |
|---|---|---|---|---|
| Revenue | 56.61 | 68.67 | 78.80 | 22.67 |
| Expense | 62.55 | 61.81 | 66.08 | 18.40 |
| Profit (PAT) | 5.73 | 5.79 | 8.97 | 3.00 |
| Total Assets | 36.54 | 49.49 | 64.57 | 77.86 |
| Company | EPS | P/E | Market Cap (Cr) |
|---|---|---|---|
| Vijaya Diagnostic Centre Limited | 13.92 | 72.36 | 18 |
Promoters: Mr. Devendra Singh Yadav, Mrs. Deepali Yadav, Mrs. Asha Yadav, and Mr. Jitendra Singh
| Shareholding | No. of Shares | Holding % |
|---|---|---|
| Promoter Holding Pre Issue | 1,10,00,000 | 99.99% |
| Promoter Holding Post Issue | 1,50,99,200 | 72.85% |
Strengths & Risks
- Heavily oversubscribed — 377.0x overall (final).
- Strong institutional (QIB) demand — 193.5x.
- Solid profit margin — 11.4%.
- Strong return on equity — 55%.
- Elevated leverage — debt/equity of 1.07.
- Lists on the exchange's SME platform, where trading is usually thinner than on the main board — selling at your price can be harder.
Compiled from this issue's live GMP, subscription, valuation and financial data, and updated as those figures change. Informational only — not investment advice. Always read the RHP before applying.
Company Information
Modern Diagnostic & Research Centre Limited, founded in 1985, is one of the leading diagnostic and healthcare-related services providers in India. The company offers a complete range of diagnostic facilities in radiology and pathology. Modern Diagnostic is involved in providing healthcare tests and services for diagnosis for individual patients, hospitals, healthcare providers, and corporate clients. The company offers many diagnostic services in radiology and pathology, such as ultrasound and colour doppler, CT scan, MRI, digital X-ray, mammography, heart lab, neuro lab, laboratory tests, ECG, CBCT, OPG, PFT, and more. They also provide services like home sample collection, where they visit the patients to take the blood sample who are unable to visit the centre. Moreover, the company currently runs 21 centers, 17 labs, and 4 diagnostic centers across 8 states.
Modern Diagnostic & Research Centre Limited., Plot No H-64,1st Floor BLK-H, Bali, Nagar City landmark near Khetar Pal, Hospital, Ramesh Nagar, West Delhi,, New Delhi, Delhi-110015, India, Email Id: [email protected]
| Purpose | Amount (Cr) |
|---|---|
| Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories | 20.69 |
| Funding Working Capital Requirement | 11.60 |
| Repayment of certain outstanding borrowings availed by the Company | 4.50 |
| General Corporate Purpose | - |
Resources & Documents
Modern Diagnostic has set a price band of Rs 85–Rs 90 per share for an issue size of Rs 37 crore. The stock listed with a 10.56% gain versus its issue price on January 07, 2026.
Modern Diagnostic & Research Centre Limited, founded in 1985, is one of the leading diagnostic and healthcare-related services providers in India. The company offers a complete range of diagnostic facilities in radiology and pathology.
The issue is promoted by Mr. Devendra Singh Yadav, Mrs. Deepali Yadav, Mrs. Asha Yadav, and Mr. Jitendra Singh with Beeline Capital Advisors Pvt. Ltd. acting as lead manager. Net proceeds will primarily be used towards Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories (Rs 21 crore) and Funding Working Capital Requirement (Rs 12 crore).
On fundamentals, the company is posting revenue growth of 14.8%, a profit margin of 11.4%, return on equity of 55.2% in its most recent reported period. Listed peers in this segment include Vijaya Diagnostic Centre Limited (P/E 72.36x, market cap Rs 18 crore) — useful reference points when evaluating the issue's pricing relative to where the broader sector is trading.
On our data-signal score, the combined signals for this issue currently read strong — the composite picture tilts positive, though not without some caveats. This is a summary of public data, not a recommendation to apply or skip. Past performance does not predict future returns — review the price chart and peer comparison below before trading.
Modern Diagnostic IPO GMP — What It Means
GMP stops mattering once the shares trade — it only ever estimated the listing price. The summary at the top of this page compares the last pre-listing GMP with how the shares actually listed.
See the full Modern Diagnostic GMP history and trend, or learn how grey market premium works and how reliable it is.
Related IPO
No comments yet. Be the first to share your opinion!